Basal nitric oxide synthesis in essential hypertension

P Forte, M Copland, L M Smith, Eric Milne, J Sutherland, N Benjamin

    Research output: Contribution to journalArticle

    322 Citations (Scopus)

    Abstract

    Background There is indirect evidence that nitric oxide (NO) synthesis in vascular endothelium of patients with hypertension is altered. The aim of this study was to estimate more directly NO production in patients with untreated essential hypertension by measurement of synthesis of inorganic nitrate, which is the end product of NO oxidation in humans. Two separate studies were undertaken in patients with hypertension and appropriate healthy controls.(1)

    Methods In the first study, ten patients and 13 controls were given a diet containing 82 mu moles nitrate per day for 2 days, with urinary and plasma nitrate measurement and 24 h ambulatory blood pressure monitoring on the 2nd day. In the second study, 11 patients and 11 controls were studied in the postabsorptive state; a bolus of 200 mg L-[N-15](2) arginine was administered intravenously over 10 min. 24 h ambulatory blood pressure monitoring was done and complete urine collections were made for the next 36 h.

    Findings In the first study, 24 h urinary nitrate excretion was lower in the hypertensive patients than in the control group (mean 450 [SEM 37] vs 760 mu moles [77] per 24 h; p<0001). There was an inverse correlation between average mean daytime ambulatory blood pressure and nitrate excretion (p=0.007; r(2)=-0.73). In the second study, mean 36 h urinary N-15 nitrate excretion was significantly lower in the hypertensive than in the control group (1313 [50] vs 2133 [142] pmoles; p<0.001). There was an inverse correlation also between average mean daytime ambulatory blood pressure and 24 h urinary N-15 nitrate excretion expressed per mmole of creatinine (p=0.002, r(2)=-0.59). In addition, total urinary N-15 nitrate excretion in the hypertensive group was significantly higher in women than in men (285 [16] vs 198 [14] mu g N-15 nitrate per kg; p=0.026).

    Interpretation These data suggest that whole-body NO production in patients with essential hypertension is diminished under basal conditions. The origin of the NO we measured is not known, and we cannot tell whether the impaired synthesis is primary or secondary to a rise in blood pressure.

    Original languageEnglish
    Pages (from-to)837-842
    Number of pages6
    JournalThe Lancet
    Volume349
    Issue number9055
    DOIs
    Publication statusPublished - 22 Mar 1997

    Keywords

    • monomethyl-L-arginine
    • nitrate
    • therapy
    • air

    Cite this

    Forte, P., Copland, M., Smith, L. M., Milne, E., Sutherland, J., & Benjamin, N. (1997). Basal nitric oxide synthesis in essential hypertension. The Lancet, 349(9055), 837-842. https://doi.org/10.1016/S0140-6736(96)07631-3

    Basal nitric oxide synthesis in essential hypertension. / Forte, P ; Copland, M ; Smith, L M ; Milne, Eric; Sutherland, J ; Benjamin, N .

    In: The Lancet, Vol. 349, No. 9055, 22.03.1997, p. 837-842.

    Research output: Contribution to journalArticle

    Forte, P, Copland, M, Smith, LM, Milne, E, Sutherland, J & Benjamin, N 1997, 'Basal nitric oxide synthesis in essential hypertension', The Lancet, vol. 349, no. 9055, pp. 837-842. https://doi.org/10.1016/S0140-6736(96)07631-3
    Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. The Lancet. 1997 Mar 22;349(9055):837-842. https://doi.org/10.1016/S0140-6736(96)07631-3
    Forte, P ; Copland, M ; Smith, L M ; Milne, Eric ; Sutherland, J ; Benjamin, N . / Basal nitric oxide synthesis in essential hypertension. In: The Lancet. 1997 ; Vol. 349, No. 9055. pp. 837-842.
    @article{57cd2f3b4d9b454b88eef4ac5ff68722,
    title = "Basal nitric oxide synthesis in essential hypertension",
    abstract = "Background There is indirect evidence that nitric oxide (NO) synthesis in vascular endothelium of patients with hypertension is altered. The aim of this study was to estimate more directly NO production in patients with untreated essential hypertension by measurement of synthesis of inorganic nitrate, which is the end product of NO oxidation in humans. Two separate studies were undertaken in patients with hypertension and appropriate healthy controls.(1)Methods In the first study, ten patients and 13 controls were given a diet containing 82 mu moles nitrate per day for 2 days, with urinary and plasma nitrate measurement and 24 h ambulatory blood pressure monitoring on the 2nd day. In the second study, 11 patients and 11 controls were studied in the postabsorptive state; a bolus of 200 mg L-[N-15](2) arginine was administered intravenously over 10 min. 24 h ambulatory blood pressure monitoring was done and complete urine collections were made for the next 36 h.Findings In the first study, 24 h urinary nitrate excretion was lower in the hypertensive patients than in the control group (mean 450 [SEM 37] vs 760 mu moles [77] per 24 h; p<0001). There was an inverse correlation between average mean daytime ambulatory blood pressure and nitrate excretion (p=0.007; r(2)=-0.73). In the second study, mean 36 h urinary N-15 nitrate excretion was significantly lower in the hypertensive than in the control group (1313 [50] vs 2133 [142] pmoles; p<0.001). There was an inverse correlation also between average mean daytime ambulatory blood pressure and 24 h urinary N-15 nitrate excretion expressed per mmole of creatinine (p=0.002, r(2)=-0.59). In addition, total urinary N-15 nitrate excretion in the hypertensive group was significantly higher in women than in men (285 [16] vs 198 [14] mu g N-15 nitrate per kg; p=0.026).Interpretation These data suggest that whole-body NO production in patients with essential hypertension is diminished under basal conditions. The origin of the NO we measured is not known, and we cannot tell whether the impaired synthesis is primary or secondary to a rise in blood pressure.",
    keywords = "monomethyl-L-arginine, nitrate, therapy, air",
    author = "P Forte and M Copland and Smith, {L M} and Eric Milne and J Sutherland and N Benjamin",
    year = "1997",
    month = "3",
    day = "22",
    doi = "10.1016/S0140-6736(96)07631-3",
    language = "English",
    volume = "349",
    pages = "837--842",
    journal = "The Lancet",
    issn = "0140-6736",
    publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
    number = "9055",

    }

    TY - JOUR

    T1 - Basal nitric oxide synthesis in essential hypertension

    AU - Forte, P

    AU - Copland, M

    AU - Smith, L M

    AU - Milne, Eric

    AU - Sutherland, J

    AU - Benjamin, N

    PY - 1997/3/22

    Y1 - 1997/3/22

    N2 - Background There is indirect evidence that nitric oxide (NO) synthesis in vascular endothelium of patients with hypertension is altered. The aim of this study was to estimate more directly NO production in patients with untreated essential hypertension by measurement of synthesis of inorganic nitrate, which is the end product of NO oxidation in humans. Two separate studies were undertaken in patients with hypertension and appropriate healthy controls.(1)Methods In the first study, ten patients and 13 controls were given a diet containing 82 mu moles nitrate per day for 2 days, with urinary and plasma nitrate measurement and 24 h ambulatory blood pressure monitoring on the 2nd day. In the second study, 11 patients and 11 controls were studied in the postabsorptive state; a bolus of 200 mg L-[N-15](2) arginine was administered intravenously over 10 min. 24 h ambulatory blood pressure monitoring was done and complete urine collections were made for the next 36 h.Findings In the first study, 24 h urinary nitrate excretion was lower in the hypertensive patients than in the control group (mean 450 [SEM 37] vs 760 mu moles [77] per 24 h; p<0001). There was an inverse correlation between average mean daytime ambulatory blood pressure and nitrate excretion (p=0.007; r(2)=-0.73). In the second study, mean 36 h urinary N-15 nitrate excretion was significantly lower in the hypertensive than in the control group (1313 [50] vs 2133 [142] pmoles; p<0.001). There was an inverse correlation also between average mean daytime ambulatory blood pressure and 24 h urinary N-15 nitrate excretion expressed per mmole of creatinine (p=0.002, r(2)=-0.59). In addition, total urinary N-15 nitrate excretion in the hypertensive group was significantly higher in women than in men (285 [16] vs 198 [14] mu g N-15 nitrate per kg; p=0.026).Interpretation These data suggest that whole-body NO production in patients with essential hypertension is diminished under basal conditions. The origin of the NO we measured is not known, and we cannot tell whether the impaired synthesis is primary or secondary to a rise in blood pressure.

    AB - Background There is indirect evidence that nitric oxide (NO) synthesis in vascular endothelium of patients with hypertension is altered. The aim of this study was to estimate more directly NO production in patients with untreated essential hypertension by measurement of synthesis of inorganic nitrate, which is the end product of NO oxidation in humans. Two separate studies were undertaken in patients with hypertension and appropriate healthy controls.(1)Methods In the first study, ten patients and 13 controls were given a diet containing 82 mu moles nitrate per day for 2 days, with urinary and plasma nitrate measurement and 24 h ambulatory blood pressure monitoring on the 2nd day. In the second study, 11 patients and 11 controls were studied in the postabsorptive state; a bolus of 200 mg L-[N-15](2) arginine was administered intravenously over 10 min. 24 h ambulatory blood pressure monitoring was done and complete urine collections were made for the next 36 h.Findings In the first study, 24 h urinary nitrate excretion was lower in the hypertensive patients than in the control group (mean 450 [SEM 37] vs 760 mu moles [77] per 24 h; p<0001). There was an inverse correlation between average mean daytime ambulatory blood pressure and nitrate excretion (p=0.007; r(2)=-0.73). In the second study, mean 36 h urinary N-15 nitrate excretion was significantly lower in the hypertensive than in the control group (1313 [50] vs 2133 [142] pmoles; p<0.001). There was an inverse correlation also between average mean daytime ambulatory blood pressure and 24 h urinary N-15 nitrate excretion expressed per mmole of creatinine (p=0.002, r(2)=-0.59). In addition, total urinary N-15 nitrate excretion in the hypertensive group was significantly higher in women than in men (285 [16] vs 198 [14] mu g N-15 nitrate per kg; p=0.026).Interpretation These data suggest that whole-body NO production in patients with essential hypertension is diminished under basal conditions. The origin of the NO we measured is not known, and we cannot tell whether the impaired synthesis is primary or secondary to a rise in blood pressure.

    KW - monomethyl-L-arginine

    KW - nitrate

    KW - therapy

    KW - air

    U2 - 10.1016/S0140-6736(96)07631-3

    DO - 10.1016/S0140-6736(96)07631-3

    M3 - Article

    VL - 349

    SP - 837

    EP - 842

    JO - The Lancet

    JF - The Lancet

    SN - 0140-6736

    IS - 9055

    ER -